diphenhydrAMINE 25 MG Cap UD (Benadryl)

diphenhydrAMINE 25 MG Cap UD (Benadryl)

Advisories: NOT TO BE ROUTINELY USED AS A SLEEP AGENT RESTRICTED TO INJECTABLE FORMULATION ONL INTRAMUSCULAR BENZTROPINE IS THE DRUG OF CHOICE FOR MEDICATION IN COMBINATION WITH
HALOPERIDOL AND LORAZEPAM
Non-Formulary Use Criteria: 1. Patient taking antipsychotic medication with extrapyramidal symptoms not responsive to benztropine and Trihexyphenidyl 2. Excessive salivation with clozapin 3. Chronic idiopathic urticaria (consider other formulary H2 blockers such as doxepin) 4. Chronic pruritus-associated dialysis 5. Non-formulary use approved via PILL LINE ONLY 6. URTICARIA: Classified according to etiology or precipitating factor-see Clinical Update article on Urticaria. All potential precipitating factors have been considered and
controlled for 7. URTICARIA: IgE levels and/or absolute eosinophil count in conditions where this is typically seen. 8. URTICARIA: Documented failure (ensuring compliance) of steroid pulse therapy (i.e prednisone 30 mg daily for 1 to 3 weeks). Be aware of any contraindication to
steroid use ( i.e. bipolar disorder) Medical Referral Center (MRC) Use Only

Dr. M Blatstein

Comments are closed.